Skip to main content

and
  1. No Access

    Chapter and Conference Paper

    Treatment of Post-Transplant Lymphomas with Anti-B-Cell Monoclonal Antibodies

    The treatment of post-transplant lymphomas still needs major improvements in order to put the patient in remission and to retain graft function. Chemotherapy is far too toxic in these patients. A more specific...

    Jeanne L. Garnier, G. Stevenson in Immunosurveillance, Immunodeficiencies and… (2002)

  2. No Access

    Chapter and Conference Paper

    Interleukin-2 Therapy: Report on 129 Patients and Three Different Schedules

    Approximately one-half of patients with renal carcinoma develop metastases, and these have a median survival of 8 months [6, 11, 12]. Metastatic renal cancer has been considered for the past 20 years as a tumo...

    S. Négrier, A. Mercatello, B. Coronel in Contemporary Research on Renal Cell Carcin… (1994)